Phase 4 Hypertension Trial, Recruiting NCT07044232 Sponsor: Aarhus University Hospital Condition: Hypertension
Back to Hypertension

Phase 4 Hypertension Trial, Recruiting

NCT07044232
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years old or older
  • You must have been diagnosed with a brain bleed (bleeding inside the brain that happened on its own, not from an outside cause), confirmed by a brain scan
  • You must have arrived at a stroke centre within 6 hours of your symptoms starting
  • Your top blood pressure number must have been above 140 at the time of admission to hospital

Who may not be able to join:

  • People whose brain bleed was caused by something specific, such as a head injury or an abnormal blood vessel (confirm with trial site)
  • People whose bleeding was considered life-threatening upon arrival at hospital
  • People who are not expected to live longer than 12 months for any reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Aarhus University Hospital
Registry
ClinicalTrials.gov
Start date
1 October 2025
Est. completion
30 September 2026

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Target blood pressure < 140 mmHg 1 hour after admission.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov